Miach Orthopaedics, Inc.

Miach Orthopaedics, Inc. is a medical technology company dedicated to improving the treatment of anterior cruciate ligament (ACL) tears. Their primary product, the Bridge-Enhanced ACL Restoration (BEAR®) Implant, offers a restorative approach that allows the torn ACL to heal naturally. This innovative implant bridges the gap between the torn ligament ends and utilizes the patient’s own blood to promote healing, moving away from traditional ACL reconstruction methods. The BEAR Implant is the first significant advancement in ACL treatment in over 30 years and received FDA De Novo approval in 2020. It is designed for skeletally mature patients with complete ACL tears and has been expanded to include children and adolescents, as well as partial ACL tears. Miach Orthopaedics is headquartered in Westborough, Massachusetts, and has garnered investment from various notable organizations to support the growth and clinical research of the BEAR Implant. The company is committed to providing resources and education to both patients and healthcare professionals regarding this novel treatment option.

• Employees 74
• Founded 2016
• Annual Revenue $65000000
• Total Funding $82500000